NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF
    1.
    发明公开
    NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF 有权
    非酒石酸脂肪肝(NAFLD)和非酒石酸性肝炎(NASH)生物标志物及其用途

    公开(公告)号:EP3296747A1

    公开(公告)日:2018-03-21

    申请号:EP17197260.7

    申请日:2014-03-10

    申请人: Somalogic, Inc.

    IPC分类号: G01N33/68

    摘要: Methods, compositions, and kits for determining whether a subject has non-alcoholic fatty liver disease (NAFLD) are provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatosis are also provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatohepatitis (NASH) are also provided.

    摘要翻译: 提供了用于确定受试者是否患有非酒精性脂肪肝病(NAFLD)的方法,组合物和试剂盒。 还提供了用于确定受试者是否具有非酒精性脂肪变性的方法,组合物和试剂盒。 还提供了用于确定受试者是否患有非酒精性脂肪性肝炎(NASH)的方法,组合物和试剂盒。